279 related articles for article (PubMed ID: 28119019)
41. Effect of three commercially available adjuvants on the production of antibodies to Pasteurella multocida in broilers.
McClimon LB; Glick B; Dick JW
Avian Dis; 1994; 38(2):354-7. PubMed ID: 7980287
[TBL] [Abstract][Full Text] [Related]
42. Dietary arginine supplementation enhances immune responses to inactivated Pasteurella multocida vaccination in mice.
Ren W; Zou L; Li N; Wang Y; Liu G; Peng Y; Ding J; Cai L; Yin Y; Wu G
Br J Nutr; 2013 Mar; 109(5):867-72. PubMed ID: 22809580
[TBL] [Abstract][Full Text] [Related]
43. Efficacy of a novel Pasteurella multocida vaccine against progressive atrophic rhinitis of swine.
Hsuan SL; Liao CM; Huang C; Winton JR; Chen ZW; Lee WC; Liao JW; Chen TH; Chiou CJ; Yeh KS; Chien MS
Vaccine; 2009 May; 27(22):2923-9. PubMed ID: 19428902
[TBL] [Abstract][Full Text] [Related]
44. Immunogenicity of iron-regulated outer membrane proteins of Pasteurella multocida A:3 in cattle: molecular characterization of the immunodominant heme acquisition system receptor (HasR) protein.
Prado ME; Dabo SM; Confer AW
Vet Microbiol; 2005 Feb; 105(3-4):269-80. PubMed ID: 15708825
[TBL] [Abstract][Full Text] [Related]
45. Efficacy of vaccination of calves against hemorrhagic septicemia with a live aroA derivative of Pasteurella multocida B:2 by two different routes of administration.
Hodgson JC; Finucane A; Dagleish MP; Ataei S; Parton R; Coote JG
Infect Immun; 2005 Mar; 73(3):1475-81. PubMed ID: 15731045
[TBL] [Abstract][Full Text] [Related]
46. Immunogenicity of a chaotropically extracted protective antigen(s) of Pasteurella multocida type A (bovine origin) against experimental pasteurellosis in mice.
Mukkur TK
J Gen Microbiol; 1979 Jul; 113(1):37-43. PubMed ID: 501332
[TBL] [Abstract][Full Text] [Related]
47. Oral immunization of rabbits against Pasteurella multocida with an alginate microsphere delivery system.
Suckow MA; Bowersock TL; Park H; Park K
J Biomater Sci Polym Ed; 1996; 8(2):131-9. PubMed ID: 8957709
[TBL] [Abstract][Full Text] [Related]
48. Immunogenicity of purified lipopolysaccharide or protein-oligosaccharide conjugates of Pasteurella multocida type 6:B in mice.
Muniandy N; Love DN; Mukkur TK
Comp Immunol Microbiol Infect Dis; 1998 Oct; 21(4):257-79. PubMed ID: 9775357
[TBL] [Abstract][Full Text] [Related]
49. Protectivity of an immunoaffinity-purified 39 kDa capsular protein of avian Pasteurella multocida in mice.
Ali HA; Sawada T; Noda K
J Vet Med Sci; 2004 Dec; 66(12):1603-4. PubMed ID: 15644617
[TBL] [Abstract][Full Text] [Related]
50. Experimental iron-inactivated Pasteurella multocida A: 1 vaccine adjuvanted with bacterial DNA is safe and protects chickens from fowl cholera.
Herath C; Kumar P; Singh M; Kumar D; Ramakrishnan S; Goswami TK; Singh A; Ram GC
Vaccine; 2010 Mar; 28(11):2284-9. PubMed ID: 20074684
[TBL] [Abstract][Full Text] [Related]
51. Purification of a cross-protective antigen from Pasteurella multocida grown in vitro and in vivo.
Rimler RB
Avian Dis; 2001; 45(3):572-80. PubMed ID: 11569729
[TBL] [Abstract][Full Text] [Related]
52. Method for quantifying the Pasteurella multocida antigen adsorbed on aluminum hydroxide adjuvant in swine atrophic rhinitis vaccine.
Yoshimura M; Honda Y; Yonemitsu E; Kuraoka K; Suenaga K
PLoS One; 2024; 19(5):e0301688. PubMed ID: 38768145
[TBL] [Abstract][Full Text] [Related]
53. Immune response in mice and swine to DNA vaccines derived from the Pasteurella multocida toxin gene.
Register KB; Sacco RE; Brockmeier SL
Vaccine; 2007 Aug; 25(32):6118-28. PubMed ID: 17590484
[TBL] [Abstract][Full Text] [Related]
54. Effects of dietary L-glutamine supplementation on specific and general defense responses in mice immunized with inactivated Pasteurella multocida vaccine.
Chen S; Liu S; Zhang F; Ren W; Li N; Yin J; Duan J; Peng Y; Liu G; Yin Y; Wu G
Amino Acids; 2014 Oct; 46(10):2365-75. PubMed ID: 24993936
[TBL] [Abstract][Full Text] [Related]
55. Passive cross-protection provided by antisera directed against in-vivo-expressed antigens of Pasteurella multocida.
Wang C; Glisson JR
Avian Dis; 1994; 38(3):506-14. PubMed ID: 7832703
[TBL] [Abstract][Full Text] [Related]
56. Protectivity conferred by immunization with intranasal recombinant outer membrane protein H from Pasteurella multocida serovar A:1 in chickens.
Thanasarasakulpong A; Poolperm P; Tankaew P; Sawada T; Sthitmatee N
J Vet Med Sci; 2015 Mar; 77(3):321-6. PubMed ID: 25650149
[TBL] [Abstract][Full Text] [Related]
57. Cross-protection of recombinant Pasteurella multocida toxin proteins against atrophic rhinitis in mice.
Wu MC; Lo YT; Wu HC; Wang HY; Chu CY
Res Vet Sci; 2021 Jul; 137():138-143. PubMed ID: 33975192
[TBL] [Abstract][Full Text] [Related]
58. In silico Analysis of Pasteurella multocida PlpE Protein Epitopes As Novel Subunit Vaccine Candidates.
Mostaan S; Ghasemzadeh A; Ehsani P; Sardari S; Shokrgozar MA; Abolhassani M; Nikbakht Brujeni G
Iran Biomed J; 2021 Jan; 25(1):41-6. PubMed ID: 33129238
[TBL] [Abstract][Full Text] [Related]
59. Vaccination against fowl cholera with acapsular Pasteurella multocida A:1.
Chung JY; Wilkie I; Boyce JD; Adler B
Vaccine; 2005 Apr; 23(21):2751-5. PubMed ID: 15780722
[TBL] [Abstract][Full Text] [Related]
60. Pasteurella challenge and ELISA serology evaluation of broiler breeders vaccinated with live cholera vaccine.
Sander JE; Resurreccion RS; Waltman WD; McMurray BL
Avian Dis; 1998; 42(1):190-3. PubMed ID: 9533100
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
